Advertisement

Topics

Merck CEO Says Drugmaker Is - Restrained' on Price Increases

17:53 EST 1 Dec 2016 | Topix

Merck & Co. keeps a disciplined approach to drug pricing and is "restrained" when it comes to price hikes, Chief Executive Officer Ken Frazier said Thursday in an interview.

Original Article: Merck CEO Says Drugmaker Is - Restrained' on Price Increases

NEXT ARTICLE

More From BioPortfolio on "Merck CEO Says Drugmaker Is - Restrained' on Price Increases"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...